Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Research

Executive Summary: Q-VD-OPh (CAS 1135695-98-5) is a highly selective, irreversible pan-caspase inhibitor with low nanomolar IC₅₀ values for caspase-1, -3, -8, and -9 (APExBIO product data). It blocks caspase-mediated apoptotic pathways, preventing cell death in both in vitro and in vivo models (Luke et al., 2022). Q-VD-OPh is cell- and brain-permeable, enabling research across multiple species and experimental settings. The compound is effective in enhancing cell viability after cryopreservation and in mitigating neurodegeneration markers in Alzheimer’s models (Q-VD-OPh: Advanced Pan-Caspase Inhibitor). APExBIO supplies Q-VD-OPh as a solid, recommended for research use only.

Biological Rationale

Apoptosis is a regulated cell death process critical for tissue homeostasis and development. Apoptotic pathways rely on a family of cysteine proteases called caspases, which orchestrate cellular dismantling. Dysregulated caspase activation is implicated in neurodegeneration, ischemia, and immune disorders (Luke et al., 2022). Pan-caspase inhibitors, such as Q-VD-OPh, are essential tools for dissecting these pathways, providing researchers the means to block multiple caspases simultaneously. This allows for the delineation of caspase-dependent versus caspase-independent cell death (e.g., lysoptosis) and supports the development of therapeutic hypotheses for diseases involving aberrant apoptosis (Q-VD-OPh: Pan-Caspase Inhibitor Transforming Apoptosis Research).

Mechanism of Action of Q-VD-OPh

Q-VD-OPh is an irreversible, cell-permeable pan-caspase inhibitor. It covalently binds to the active sites of caspases through a quinoline-Val-Asp(OMe)-CH2-O-phenoxy (OPh) scaffold. The compound inhibits caspase-1 (IC₅₀ ≈ 50 nM), caspase-3 (≈25 nM), caspase-8 (≈100 nM), and caspase-9 (≈430 nM), as measured by fluorometric enzyme assays at 25°C in buffered conditions (pH 7.4) (APExBIO). By blocking these caspases, Q-VD-OPh inhibits both intrinsic (mitochondrial, caspase-9/3) and extrinsic (death receptor, caspase-8/10) apoptotic pathways. The compound also impedes caspase-12-mediated apoptosis associated with endoplasmic reticulum stress. Due to its chemical structure, Q-VD-OPh is resistant to hydrolysis and remains active in cellular and animal models. Its cell and brain permeability have been validated in human, mouse, and rat systems (Q-VD-OPh: Advanced Pan-Caspase Inhibitor).

Evidence & Benchmarks

• Q-VD-OPh irreversibly inhibits recombinant human caspase-3 activity with an IC₅₀ of 25 nM at 25°C, pH 7.4 (APExBIO, product page).
• In vitro, Q-VD-OPh prevents actinomycin D-induced apoptotic cell death in mammalian cell lines, demonstrating robust caspase-3/7 inhibition (Luke et al., 2022).
• Intraperitoneal administration of Q-VD-OPh (10 mg/kg, 3x/week, for 3 months) in Alzheimer’s mouse models reduced caspase-7 activation and tau pathology (see application note).
• Q-VD-OPh is highly soluble in DMSO (≥25.67 mg/mL) and ethanol (≥28.75 mg/mL), but insoluble in water; stock solutions retain stability at –20°C for several months (APExBIO, product data).
• Enhances post-thaw viability of human, mouse, and rat cells under standard cryoprotectant protocols (Q-VD-OPh: The Pan-Caspase Inhibitor Transforming Apoptosis Research).

Applications, Limits & Misconceptions

Q-VD-OPh is widely utilized in apoptosis research to dissect caspase-dependent cell death across species. Applications include disease modeling, neurodegeneration studies, and enhancing cell viability after cryopreservation. It is especially valuable in differentiating apoptosis from lysosome-dependent cell death (LDCD) or lysoptosis, as caspase inhibition does not block LDCD pathways (Luke et al., 2022). Q-VD-OPh is not a universal cell death inhibitor; it does not block necroptosis, ferroptosis, or cathepsin-mediated lysis.

Common Pitfalls or Misconceptions

• Q-VD-OPh does not inhibit lysosome-dependent cell death (LDCD) when cathepsin release is the executioner (Luke et al., 2022).
• It is ineffective against necroptosis, ferroptosis, and pyroptosis, which are caspase-independent.
• Q-VD-OPh is not water-soluble; incorrect solvent selection will lead to precipitation and loss of activity (APExBIO, product page).
• Long-term storage of Q-VD-OPh solutions (>1 month) can reduce potency; prepare fresh stocks when possible.
• It is not for diagnostic or therapeutic use in humans.

This article expands upon Strategic Dissection of Apoptosis: Q-VD-OPh and the Evolving Cell Death Landscape by providing a granular, evidence-based perspective on Q-VD-OPh's mechanistic boundaries and workflow parameters.

Workflow Integration & Parameters

Q-VD-OPh is supplied as a solid by APExBIO (product page). It should be dissolved in DMSO or ethanol for stock solutions (≥25.67 mg/mL in DMSO; ≥28.75 mg/mL in ethanol). Working concentrations range from 1–50 μM in cell culture, depending on cell type and experimental design. For in vivo studies, intraperitoneal injection at 10 mg/kg is established for mouse models. Stock solutions are stable at –20°C for several months; avoid repeated freeze-thaw cycles. For cryopreservation, add Q-VD-OPh to standard cryoprotectant cocktails to improve viability post-thaw. Always validate caspase inhibition with control assays.

For detailed troubleshooting and protocol optimization, Q-VD-OPh (SKU A1901): Enhancing Apoptosis Research with Reproducibility offers scenario-driven answers and further protocol guidance, whereas this article synthesizes recent mechanistic advances and practical benchmarks.

Conclusion & Outlook

Q-VD-OPh is a gold-standard tool for pan-caspase inhibition in apoptosis research, offering high potency, selectivity, and workflow versatility across in vitro and in vivo models. It enables researchers to dissect the role of caspases in regulated cell death while clarifying the boundaries between apoptosis and alternative pathways like lysoptosis. As cell death taxonomy evolves, precise inhibitors like Q-VD-OPh from APExBIO remain essential for translational and discovery research. For the latest specifications and ordering information, consult the Q-VD-OPh product page.